Siplizumab (Anti-CD2), 1mg*5

Siplizumab (Anti-CD2), 1mg*5

Tafasitamab (Anti-CD19), 1mg

Tafasitamab (Anti-CD19), 1mg

Siplizumab (Anti-CD2), 1mg*25

19.336,31 RON
SKU
SKM_A2562_1mg*25

Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. MW:145.5 KD.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. MW:145.5 KD.